RETACRIT 30 000 IU/0.75 ml, solution for injection in a pre-filled syringe syringe, 0.75 ml
Active ingredients: ÉPOÉTINE ZÊTA
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 0.75 mlintraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RETACRIT 30 000 UI/0,75 mL, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 0,75 ml avec dispositif(s) de sécurité de l'aiguille
- Marketing authorisation holder
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Jun 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63450968CIP73001220CIP133400930012208Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉPOÉTINE ZÊTAsolution | 30000 UI · une seringue préremplie de 0,75 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.